15,424 Shares in HCA Healthcare, Inc. $HCA Bought by Northwestern Mutual Wealth Management Co.

Posted by Stanley Muller on Aug 24th, 2026

Northwestern Mutual Wealth Management Co. purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 15,424 shares of the company’s stock, valued at approximately $6,014,000.

A number of other large investors have also added to or reduced their stakes in the business. Nomura Asset Management Co. Ltd. increased its holdings in HCA Healthcare by 6.2% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 64,237 shares of the company’s stock valued at $29,990,000 after purchasing an additional 3,724 shares during the period. Sunbelt Securities Inc. increased its stake in shares of HCA Healthcare by 171.7% in the first quarter. Sunbelt Securities Inc. now owns 6,242 shares of the company’s stock valued at $2,954,000 after buying an additional 3,945 shares during the period. Advisors Capital Management LLC boosted its holdings in HCA Healthcare by 61.5% in the fourth quarter. Advisors Capital Management LLC now owns 6,836 shares of the company’s stock valued at $3,192,000 after acquiring an additional 2,604 shares during the last quarter. Arrowstreet Capital Limited Partnership raised its holdings in HCA Healthcare by 11.9% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 2,311,112 shares of the company’s stock worth $1,078,966,000 after purchasing an additional 245,887 shares during the last quarter. Finally, Liberty Wealth Management LLC bought a new stake in shares of HCA Healthcare in the 4th quarter valued at $1,905,000. Institutional investors own 62.73% of the company’s stock.

HCA Healthcare Price Performance

NYSE:HCA opened at $429.08 on Monday. HCA Healthcare, Inc. has a one year low of $353.99 and a one year high of $556.52. The company has a market cap of $92.90 billion, a PE ratio of 14.36, a PEG ratio of 1.49 and a beta of 1.10. The firm has a 50-day moving average of $397.16 and a 200-day moving average of $443.77.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings results on Friday, July 24th. The company reported $7.59 EPS for the quarter, beating analysts’ consensus estimates of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to analyst estimates of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.HCA Healthcare’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.84 EPS. On average, equities research analysts expect that HCA Healthcare, Inc. will post 29.47 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Wednesday, September 16th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is currently 10.45%.

Wall Street Analyst Weigh In

HCA has been the subject of a number of analyst reports. Jefferies Financial Group set a $450.00 target price on shares of HCA Healthcare in a research note on Tuesday, July 14th. Weiss Ratings lowered HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 9th. Barclays decreased their target price on HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a research note on Monday, July 27th. Oppenheimer cut their price target on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating on the stock in a report on Monday, July 27th. Finally, Cantor Fitzgerald dropped their target price on shares of HCA Healthcare from $588.00 to $525.00 and set an “overweight” rating on the stock in a research report on Tuesday, July 7th. Fourteen research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, HCA Healthcare has an average rating of “Moderate Buy” and a consensus price target of $462.64.

View Our Latest Research Report on HCA

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.